• Home
  • About
  • Portfolio
  • Meet the Team
  • News
  • Contact
  • Investor Portal

  • info@chv.vc

  • 129 South Street, 4th Floor, Boston, MA 02111

Home / News / Conformal

Conformal


Conformal Medical Announces Positive One-Year Data from its Left Atrial Appendage Closure Performed Under Conscious Sedation Study
  • February 3, 2023
  • -
  • Conformal
JSCAI Publishes Peer-Reviewed Article Highlighting Effective Performance of Conformal Medical’s Left Atrial Appendage (CLAAS®) Device
  • January 8, 2023
  • -
  • Conformal
Conformal Medical Announces Leadership Transition
  • September 13, 2022
  • -
  • Conformal
Conformal Medical Announces Launch of CONFORM Pivotal Trial
  • June 17, 2022
  • -
  • Conformal
Conformal Medical Appoints George Fazio to Board of Directors
  • November 19, 2020
  • -
  • Conformal
Conformal Medical’s CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference
  • October 16, 2020
  • -
  • Conformal
Novel Conformable Foam-Based Implant for Left Atrial Appendage Closure: Conformable EFS Experience
  • October 15, 2020
  • -
  • Conformal
Conformal Medical Secures $85M in Series C Financing
  • August 6, 2020
  • -
  • Conformal
Show More

Let’s Connect.

Contact Us
https://chv.vc/wp-content/uploads/2020/08/footer-logo.png

Sitemap

  • Home
  • About
  • Portfolio
  • Meet the Team
  • News
  • Contact
  • Investor Portal

About

Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs.

Contact

  • info@chv.vc

Boston Web Design by GoingClear